Extramedullary Involvement of Lymph Nodes in Multiple Myeloma

1. Raab M S, Podar K, Breitkreutz I et al. Multiple myeloma. Lancet 2009; 374:324 - 339.10.1016/S0140-6736(09)60221-XSearch in Google Scholar

2. Joan Blade, Carlos Fernandez de Larrea, Laura Rosinol. Extramedullary involvement in multiple myeloma. Haematologica. 2012 Nov; 97(11): 1618-1619.10.3324/haematol.2012.078519348743123125242Open DOISearch in Google Scholar

3. Blade J, Fernandez de Larrea C, Rosinol L, Cibeira MT, Jimenez R, Powles R. SoftTissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. J Clin Oncol. 2011;29(28):3805-12.10.1200/JCO.2011.34.929021900099Open DOISearch in Google Scholar

4. Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, Potter MN, Ethell ME, Shaw BE, Morgan GJ. The impact of extramedullary disease at presentation on the outcome of myeloma. Leuk Lymphoma. 2009 Feb;50(2):230-5.10.1080/1042819080265775119197724Search in Google Scholar

5. Varettoni M, Corso A, Pica G, Mangiacavalli S, Pascutto C, Lazzarino M. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: longitudinal study on 1,003 consecutive patients. Ann Oncol. 2009;21(2):325-30.10.1093/annonc/mdp32919633044Search in Google Scholar

6. Wu P, Davies FE, Boyd K, Thomas K, Dines S, Saso RM, et al. The impact of extramedullary disease at presentation in outcome of myeloma. Leuk Lymphoma. 2009;50(2):230-5.10.1080/10428190802657751Search in Google Scholar

7. Blade J, Lust J, Kyle RA. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 patients. J Clin Oncol. 1994;12(11):2398-404.10.1200/JCO.1994.12.11.23987964956Open DOISearch in Google Scholar

8. Blade J, Kyle RA, Greipp PR. Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Heamatol. 1996;93(2):345-51.10.1046/j.1365-2141.1996.5191061.x8639427Search in Google Scholar

9. Soutar R, Lucraft H, Jackson G, Reece A, Bird J, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004 Mar;124(6):717-26.10.1111/j.1365-2141.2004.04834.x15009059Search in Google Scholar

10. Menke DM1, Horny HP, Griesser H, Tiemann M, Katzmann JA, et al. Primary lymph node plasmacytomas (plasmacytic lymphomas). Am J Clin Pathol. 2001 Jan;115(1):119- 26.10.1309/L2GR-PCFM-G4A3-GHDW11190797Search in Google Scholar

11. Masood A, Hudhud KH, Hegazi A, Syed G. Mediastinal plasmacytoma with multiple myeloma presenting as a diagnostic dilemma. Cases J. 2008 Aug 21;1(1):116.10.1186/1757-1626-1-116253329818717993Search in Google Scholar

12. Miyazaki T, Kohno S, Sakamoto A, Komori K, Sasagawa I et al. A rare case of extramedullary plasmacytoma in the mediastinum. Intern Med. 1992 Dec;31(12):1363-5.10.2169/internalmedicine.31.13631300172Search in Google Scholar

13. Kazama T, Ng CS, Giralt SA. Multiphasic CT and MRI appearances of extramedullary multiple myeloma involving the stomach, pancreas, and bladder. Clin Imaging. 2005 JulAug;29(4):263-5.10.1016/j.clinimag.2004.11.00215967318Search in Google Scholar

14. Aguado B, Inigo B, Sastre JL, Oriol A. Extramedullary plasmacytomas in the context of multiple myeloma. Adv Ther. 2011 Nov;28 Suppl 7:7-13.10.1007/s12325-011-0073-622105528Open DOISearch in Google Scholar

15. Touzeau C, Moreau P. How I treat extramedullary myeloma. Blood. 2016 Feb 25;127(8):971-6. 10.1182/blood-2015-07-63538326679866Search in Google Scholar

16. Rosiñol L, Cibeira MT, Blade´ J, et al: Extramedullary multiple myeloma escapes the effect of thalidomide. Haematologica 89:832-836, 2004.Search in Google Scholar

17. Avigdor A, Raanani P, Levi I, et al: Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma. Leuk Lymphoma 42:683-687, 2001. 10.3109/1042819010909933011697498Search in Google Scholar

18. Myers B, Grimley C, Crouch D, et al: Lack of response to thalidomide in plasmacytomas. Br J Haematol 115:234, 2001.10.1046/j.1365-2141.2001.115_1cr-6.xSearch in Google Scholar

19. Nakazato T, Suzuki K, Mihara A, et al. Refractory plasmablastic type myeloma with multiple extra medullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone. Intern Med. 2009;48:1827-1832.10.2169/internalmedicine.48.214219834276Open DOISearch in Google Scholar

20. Gonzalez-Porras JR, Gonzalez M, Garcia-Sanz R, et al. Thalidomide in combination with cyclophosphamide and dexamethasone (thacydex) is effective in soft-tissue plasmacytomas. Br J Haematol. 2002;119:883-884.10.1046/j.1365-2141.2002.03870_8.x12437681Search in Google Scholar